5P01AG003991-39 |
2022 |
$188550 |
8866 |
Dissecting the Genetic Architecture of Cognitive Reserve and Resilience |
CRUCHAGA, CARLOS |
5P01AG003991-39 |
2022 |
$159555 |
8867 |
Smartphone-Based "Burst" Cognitive Assessments |
HASSENSTAB, JASON J |
5P01AG003991-39 |
2022 |
$191841 |
8859 |
Core A: Administration Core |
MORRIS, JOHN |
5P01AG003991-39 |
2022 |
$831706 |
8860 |
Core B: Clinical Core |
MORRIS, JOHN |
5P01AG003991-39 |
2022 |
$190463 |
8861 |
Core C: Biostatistics Core |
XIONG, CHENGJIE |
5P01AG003991-39 |
2022 |
$441690 |
8862 |
Core D: Neuropathology Core |
PERRIN, RICHARD JUSTIN |
5P01AG003991-39 |
2022 |
$1282382 |
8863 |
Core E: Imaging Core |
BENZINGER, TAMMIE LEE SMITH |
5P01AG003991-39 |
2022 |
$149266 |
8864 |
Characterization of molecular biomarker profiles of AD throughout its pathobiolgical continuum |
MORRIS, JOHN |
5P01AG003991-39 |
2022 |
$214444 |
8865 |
Sleep and Orexin: Potential Markers of Progression from Preclinical to Mildly Symptomatic Alzheimer's Disease |
LUCEY, BRENDAN PATRICK |
5P01AG003991-38 |
2021 |
$191842 |
8859 |
Core A: Administration Core |
MORRIS, JOHN |
5P01AG003991-38 |
2021 |
$831706 |
8860 |
Core B: Clinical Core |
MORRIS, JOHN |
5P01AG003991-38 |
2021 |
$190463 |
8861 |
Core C: Biostatistics Core |
XIONG, CHENGJIE |
5P01AG003991-38 |
2021 |
$441690 |
8862 |
Core D: Neuropathology Core |
PERRIN, RICHARD JUSTIN |
5P01AG003991-38 |
2021 |
$1230321 |
8863 |
Core E: Imaging Core |
BENZINGER, TAMMIE LEE SMITH |
5P01AG003991-38 |
2021 |
$149266 |
8864 |
Characterization of molecular biomarker profiles of AD throughout its pathobiolgical continuum |
MORRIS, JOHN |
5P01AG003991-38 |
2021 |
$212554 |
8865 |
Sleep and Orexin: Potential Markers of Progression from Preclinical to Mildly Symptomatic Alzheimer's Disease |
LUCEY, BRENDAN PATRICK |
5P01AG003991-38 |
2021 |
$188550 |
8866 |
Dissecting the Genetic Architecture of Cognitive Reserve and Resilience |
CRUCHAGA, CARLOS |
5P01AG003991-38 |
2021 |
$159554 |
8867 |
Smartphone-Based "Burst" Cognitive Assessments |
HASSENSTAB, JASON J |
5P01AG003991-37 |
2020 |
$191743 |
8859 |
Core A: Administration Core |
MORRIS, JOHN |
5P01AG003991-37 |
2020 |
$831265 |
8860 |
Core B: Clinical Core |
MORRIS, JOHN |
5P01AG003991-37 |
2020 |
$190362 |
8861 |
Core C: Biostatistics Core |
XIONG, CHENGJIE |
5P01AG003991-37 |
2020 |
$441456 |
8862 |
Core D: Neuropathology Core |
PERRIN, RICHARD JUSTIN |
5P01AG003991-37 |
2020 |
$1180581 |
8863 |
Core E: Imaging Core |
BENZINGER, TAMMIE LEE SMITH |
5P01AG003991-37 |
2020 |
$149187 |
8864 |
Characterization of molecular biomarker profiles of AD throughout its pathobiolgical continuum |
MORRIS, JOHN |
5P01AG003991-37 |
2020 |
$203288 |
8865 |
Sleep and Orexin: Potential Markers of Progression from Preclinical to Mildly Symptomatic Alzheimer's Disease |
LUCEY, BRENDAN PATRICK |
5P01AG003991-37 |
2020 |
$189237 |
8866 |
Dissecting the Genetic Architecture of Cognitive Reserve and Resilience |
CRUCHAGA, CARLOS |
5P01AG003991-37 |
2020 |
$159470 |
8867 |
Smartphone-Based 'Burst' Cognitive Assessments |
HASSENSTAB, JASON J |
2P01AG003991-36 |
2019 |
$189556 |
8861 |
Core C: Biostatistics Core |
XIONG, CHENGJIE |
2P01AG003991-36 |
2019 |
$470412 |
8862 |
Core D: Neuropathology Core |
PERRIN, RICHARD JUSTIN |
2P01AG003991-36 |
2019 |
$1130092 |
8863 |
Core E: Imaging Core |
BENZINGER, TAMMIE LEE SMITH |
2P01AG003991-36 |
2019 |
$148555 |
8864 |
Characterization of molecular biomarker profiles of AD throughout its pathobiolgical continuum |
MORRIS, JOHN |
2P01AG003991-36 |
2019 |
$202155 |
8865 |
Sleep and Orexin: Potential Markers of Progression from Preclinical to Mildly Symptomatic Alzheimer's Disease |
LUCEY, BRENDAN PATRICK |
2P01AG003991-36 |
2019 |
$187962 |
8866 |
Dissecting the Genetic Architecture of Cognitive Reserve and Resilience |
CRUCHAGA, CARLOS |
2P01AG003991-36 |
2019 |
$326518 |
8867 |
Smartphone-Based 'Burst' Cognitive Assessments |
HASSENSTAB, JASON J |
2P01AG003991-36 |
2019 |
$190929 |
8859 |
Core A: Administration Core |
MORRIS, JOHN |
2P01AG003991-36 |
2019 |
$816012 |
8860 |
Core B: Clinical Core |
MORRIS, JOHN |
5P01AG003991-35 |
2018 |
$279057 |
8394 |
Core A: Administrative Core |
MORRIS, JOHN |
5P01AG003991-35 |
2018 |
$642177 |
8395 |
Core B: Clinical Core |
MORRIS, JOHN |
5P01AG003991-35 |
2018 |
$260960 |
8396 |
Core C: Data Management and Biostatistics |
XIONG, CHENGJIE |
5P01AG003991-35 |
2018 |
$293336 |
8397 |
Core D: Neuropathology |
CAIRNS, NIGEL JOHN |
5P01AG003991-35 |
2018 |
$413006 |
8398 |
Core E: Imaging |
BENZINGER, TAMMIE LEE SMITH |
5P01AG003991-35 |
2018 |
$276868 |
8399 |
Project 1: Cognitive and Functional Indicators of Transition to Symptomatic AD |
MORRIS, JOHN |
5P01AG003991-35 |
2018 |
$438889 |
8400 |
Project 2: Sleep: Potential Prognostic and Theranostic Marker for Preclinical AD |
HOLTZMAN, DAVID M |
5P01AG003991-35 |
2018 |
$276013 |
8401 |
Project 3: Identification of genetic variants associated with rate of disease pro |
CRUCHAGA, CARLOS |
5P01AG003991-34 |
2017 |
$286677 |
8397 |
Core D: Neuropathology |
CAIRNS, NIGEL JOHN |
5P01AG003991-34 |
2017 |
$419642 |
8398 |
Core E: Imaging |
BENZINGER, TAMMIE LEE SMITH |
5P01AG003991-34 |
2017 |
$2886316 |
None |
HEALTHY AGING AND SENILE DEMENTIA |
MORRIS, JOHN |
5P01AG003991-34 |
2017 |
$268378 |
8399 |
PROJECT 1: COGNITIVE AND FUNCTIONAL INDICATORS OF TRANSITION TO SYMPTOMATIC AD |
MORRIS, JOHN |
5P01AG003991-34 |
2017 |
$448401 |
8400 |
PROJECT 2: SLEEP: POTENTIAL PROGNOSTIC AND THERANOSTIC MARKER FOR PRECLINICAL AD |
HOLTZMAN, DAVID M |
5P01AG003991-34 |
2017 |
$267428 |
8401 |
PROJECT 3: IDENTIFICATION OF GENETIC VARIANTS ASSOCIATED WITH RATE OF DISEASE PRO |
CRUCHAGA, CARLOS |
5P01AG003991-34 |
2017 |
$270811 |
8394 |
Core A: Administrative Core |
MORRIS, JOHN |
5P01AG003991-34 |
2017 |
$674277 |
8395 |
Core B: Clinical Core |
MORRIS, JOHN |
5P01AG003991-34 |
2017 |
$250702 |
8396 |
Core C: Data Management and Biostatistics |
XIONG, CHENGJIE |
5P01AG003991-33 |
2016 |
$153681 |
8394 |
CORE A: ADMINISTRATIVE CORE |
MORRIS, JOHN |
5P01AG003991-33 |
2016 |
$516802 |
8395 |
CORE B: CLINICAL CORE |
MORRIS, JOHN |
5P01AG003991-33 |
2016 |
$135586 |
8396 |
CORE C: DATA MANAGEMENT AND BIOSTATISTICS |
XIONG, CHENGJIE |
5P01AG003991-33 |
2016 |
$167962 |
8397 |
CORE D: NEUROPATHOLOGY |
CAIRNS, NIGEL JOHN |
5P01AG003991-33 |
2016 |
$287633 |
8398 |
CORE E: IMAGING |
BENZINGER, TAMMIE LEE SMITH |
3P01AG003991-33S1 |
2016 |
$995526 |
None |
HEALTHY AGING AND SENILE DEMENTIA |
MORRIS, JOHN |
5P01AG003991-33 |
2016 |
$1864797 |
None |
HEALTHY AGING AND SENILE DEMENTIA |
MORRIS, JOHN |
5P01AG003991-33 |
2016 |
$136475 |
8399 |
PROJECT 1: COGNITIVE AND FUNCTIONAL INDICATORS OF TRANSITION TO SYMPTOMATIC AD |
MORRIS, JOHN |
5P01AG003991-33 |
2016 |
$313516 |
8400 |
PROJECT 2: SLEEP: POTENTIAL PROGNOSTIC AND THERANOSTIC MARKER FOR PRECLINICAL AD |
HOLTZMAN, DAVID M |
5P01AG003991-33 |
2016 |
$153142 |
8401 |
PROJECT 3: IDENTIFICATION OF GENETIC VARIANTS ASSOCIATED WITH RATE OF DISEASE PRO |
CRUCHAGA, CARLOS |
5P01AG003991-32 |
2015 |
$132380 |
8399 |
PROJECT 1: COGNITIVE AND FUNCTIONAL INDICATORS OF TRANSITION TO SYMPTOMATIC AD |
MORRIS, JOHN |
5P01AG003991-32 |
2015 |
$304110 |
8400 |
PROJECT 2: SLEEP: POTENTIAL PROGNOSTIC AND THERANOSTIC MARKER FOR PRECLINICAL AD |
HOLTZMAN, DAVID M |
5P01AG003991-32 |
2015 |
$148547 |
8401 |
PROJECT 3: IDENTIFICATION OF GENETIC VARIANTS ASSOCIATED WITH RATE OF DISEASE PRO |
CRUCHAGA, CARLOS |
5P01AG003991-32 |
2015 |
$149070 |
8394 |
CORE A: ADMINISTRATIVE CORE |
MORRIS, JOHN |
5P01AG003991-32 |
2015 |
$501300 |
8395 |
CORE B: CLINICAL CORE |
MORRIS, JOHN |
5P01AG003991-32 |
2015 |
$131519 |
8396 |
CORE C: DATA MANAGEMENT AND BIOSTATISTICS |
XIONG, CHENGJIE |
5P01AG003991-32 |
2015 |
$162924 |
8397 |
CORE D: NEUROPATHOLOGY |
CAIRNS, NIGEL JOHN |
5P01AG003991-32 |
2015 |
$279004 |
8398 |
CORE E: IMAGING |
BENZINGER, TAMMIE LEE SMITH |
2P01AG003991-31A1 |
2014 |
$153680 |
None |
CORE A: ADMINISTRATIVE CORE |
MORRIS, JOHN |
2P01AG003991-31A1 |
2014 |
$516802 |
8395 |
CORE B: CLINICAL CORE |
MORRIS, JOHN |
2P01AG003991-31A1 |
2014 |
$135586 |
8396 |
CORE C: DATA MANAGEMENT AND BIOSTATISTICS |
XIONG, CHENGJIE |
2P01AG003991-31A1 |
2014 |
$176162 |
8397 |
CORE D: NEUROPATHOLOGY |
CAIRNS, NIGEL JOHN |
2P01AG003991-31A1 |
2014 |
$287633 |
8398 |
CORE E: IMAGING |
BENZINGER, TAMMIE LEE SMITH |
2P01AG003991-31A1 |
2014 |
$132759 |
8399 |
PROJECT 1: COGNITIVE AND FUNCTIONAL INDICATORS OF TRANSITION TO SYMPTOMATIC AD |
MORRIS, JOHN |
2P01AG003991-31A1 |
2014 |
$313516 |
8400 |
PROJECT 2: SLEEP: POTENTIAL PROGNOSTIC AND THERANOSTIC MARKER FOR PRECLINICAL AD |
HOLTZMAN, DAVID M |
2P01AG003991-31A1 |
2014 |
$153142 |
8401 |
PROJECT 3: IDENTIFICATION OF GENETIC VARIANTS ASSOCIATED WITH RATE OF DISEASE PRO |
CRUCHAGA, CARLOS |
5P01AG003991-30 |
2013 |
$204056 |
8681 |
NEUROPATHOLOGY |
CAIRNS, NIGEL JOHN |
5P01AG003991-30 |
2013 |
$146260 |
8683 |
PRECLINICAL ALZHEMER'S DISEASE PREDICTS POST-STROKE DEMENTIA |
MORRIS, JOHN |
5P01AG003991-30 |
2013 |
$108935 |
8686 |
SEQUENCE VARIATION IN GENES FOR BIOMAKERS PROTEINS AND AGE/ONSET ALZHEIMER'S DIS |
GOATE, ALISON M |
5P01AG003991-30 |
2013 |
$139173 |
8678 |
ADMINISTRATIVE CORE |
MORRIS, JOHN |
5P01AG003991-30 |
2013 |
$168988 |
8684 |
ANTECEDENT BIOMAKERS OF AD IN CSF AND PLASMA |
HOLTZMAN, DAVID M |
5P01AG003991-30 |
2013 |
$87867 |
8680 |
BIOSTATISTICS |
XIONG, CHENGJIE |
5P01AG003991-30 |
2013 |
$520338 |
8679 |
CLINICAL |
MORRIS, JOHN |
5P01AG003991-30 |
2013 |
$182007 |
8682 |
IMAGING |
MINTUN, MARK A. |
5P01AG003991-30 |
2013 |
$134171 |
8685 |
MARKERS FOR DAT: CONTROL; VARIABILITY AND PERSONALITY |
BALOTA, DAVID A |
5P01AG003991-29 |
2012 |
$150114 |
8678 |
ADMINISTRATIVE CORE |
MORRIS, JOHN |
5P01AG003991-29 |
2012 |
$179927 |
8684 |
ANTECEDENT BIOMAKERS OF AD IN CSF AND PLASMA |
HOLTZMAN, DAVID M |
5P01AG003991-29 |
2012 |
$98808 |
8680 |
BIOSTATISTICS |
XIONG, CHENGJIE |
5P01AG003991-29 |
2012 |
$531273 |
8679 |
CLINICAL |
MORRIS, JOHN |
5P01AG003991-29 |
2012 |
$1831586 |
None |
HEALTHY AGING AND SENILE DEMENTIA |
MORRIS, JOHN |
5P01AG003991-29 |
2012 |
$192945 |
8682 |
IMAGING |
MINTUN, MARK A. |
5P01AG003991-29 |
2012 |
$145133 |
8685 |
MARKERS FOR DAT: CONTROL; VARIABILITY AND PERSONALITY |
BALOTA, DAVID A |
5P01AG003991-29 |
2012 |
$214996 |
8681 |
NEUROPATHOLOGY |
CAIRNS, NIGEL JOHN |
5P01AG003991-29 |
2012 |
$190820 |
8683 |
PRECLINICAL ALZHEMER'S DISEASE PREDICTS POST-STROKE DEMENTIA |
MORRIS, JOHN |
5P01AG003991-29 |
2012 |
$127570 |
8686 |
SEQUENCE VARIATION IN GENES FOR BIOMAKERS PROTEINS AND AGE/ONSET ALZHEIMER'S DIS |
GOATE, ALISON M |
5P01AG003991-28 |
2011 |
$112071 |
8678 |
ADMINISTRATIVE CORE |
MORRIS, JOHN |
5P01AG003991-28 |
2011 |
$134333 |
8684 |
ANTECEDENT BIOMAKERS OF AD IN CSF AND PLASMA |
HOLTZMAN, DAVID M |
5P01AG003991-28 |
2011 |
$73767 |
8680 |
BIOSTATISTICS |
XIONG, CHENGJIE |
5P01AG003991-28 |
2011 |
$396643 |
8679 |
CLINICAL |
MORRIS, JOHN |
5P01AG003991-28 |
2011 |
$144048 |
8682 |
IMAGING |
MINTUN, MARK A. |
5P01AG003991-28 |
2011 |
$105128 |
8685 |
MARKERS FOR DAT: CONTROL; VARIABILITY AND PERSONALITY |
BALOTA, DAVID A |
5P01AG003991-28 |
2011 |
$160514 |
8681 |
NEUROPATHOLOGY |
CAIRNS, NIGEL JOHN |
5P01AG003991-28 |
2011 |
$188175 |
8683 |
PRECLINICAL ALZHEMER'S DISEASE PREDICTS POST-STROKE DEMENTIA |
MORRIS, JOHN |
5P01AG003991-28 |
2011 |
$101168 |
8686 |
SEQUENCE VARIATION IN GENES FOR BIOMAKERS PROTEINS AND AGE/ONSET ALZHEIMER'S DIS |
GOATE, ALISON M |
5P01AG003991-27 |
2010 |
$125904 |
8680 |
BIOSTATISTICS |
XIONG, CHENGJIE |
5P01AG003991-27 |
2010 |
$676991 |
8679 |
CLINICAL |
MORRIS, JOHN |
5P01AG003991-27 |
2010 |
$245861 |
8682 |
IMAGING |
MINTUN, MARK A. |
5P01AG003991-27 |
2010 |
$179502 |
8685 |
MARKERS FOR DAT: CONTROL; VARIABILITY AND PERSONALITY |
BALOTA, DAVID A |
5P01AG003991-27 |
2010 |
$273966 |
8681 |
NEUROPATHOLOGY |
CAIRNS, NIGEL JOHN |
5P01AG003991-27 |
2010 |
$309717 |
8683 |
PRECLINICAL ALZHEMER'S DISEASE PREDICTS POST-STROKE DEMENTIA |
MORRIS, JOHN |
5P01AG003991-27 |
2010 |
$179376 |
8686 |
SEQUENCE VARIATION IN GENES FOR BIOMAKERS PROTEINS AND AGE/ONSET ALZHEIMER'S DIS |
GOATE, ALISON M |
5P01AG003991-27 |
2010 |
$191282 |
8678 |
ADMINISTRATIVE CORE |
MORRIS, JOHN |
5P01AG003991-27 |
2010 |
$229278 |
8684 |
ANTECEDENT BIOMAKERS OF AD IN CSF AND PLASMA |
HOLTZMAN, DAVID M |
2P01AG003991-26 |
2009 |
$168619 |
8678 |
ADMINISTRATIVE CORE |
MORRIS, JOHN |
2P01AG003991-26 |
2009 |
$202110 |
8684 |
ANTECEDENT BIOMAKERS OF AD IN CSF AND PLASMA |
HOLTZMAN, DAVID M |
2P01AG003991-26 |
2009 |
$110985 |
8680 |
BIOSTATISTICS |
XIONG, CHENGJIE |
2P01AG003991-26 |
2009 |
$596778 |
8679 |
CLINICAL |
MORRIS, JOHN |
3P01AG003991-25S1 |
2009 |
$250000 |
None |
HEALTHY AGING AND SENILE DEMENTIA |
MORRIS, JOHN |
2P01AG003991-26 |
2009 |
$216734 |
8682 |
IMAGING |
MINTUN, MARK A. |
2P01AG003991-26 |
2009 |
$162536 |
8685 |
MARKERS FOR DAT: CONTROL; VARIABILITY AND PERSONALITY |
BALOTA, DAVID A |
2P01AG003991-26 |
2009 |
$248680 |
8681 |
NEUROPATHOLOGY |
CAIRNS, NIGEL JOHN |
2P01AG003991-26 |
2009 |
$247336 |
8683 |
PRECLINICAL ALZHEMER'S DISEASE PREDICTS POST-STROKE DEMENTIA |
MORRIS, JOHN |
2P01AG003991-26 |
2009 |
$162534 |
8686 |
SEQUENCE VARIATION IN GENES FOR BIOMAKERS PROTEINS AND AGE/ONSET ALZHEIMER'S DIS |
GOATE, ALISON M |
5P01AG003991-25 |
2008 |
$238259 |
9003 |
CORE--NEUROPATHOLOGY CORE |
MCKEEL, DANIEL W |
5P01AG003991-25 |
2008 |
$154420 |
9002 |
CORE--PSYCHOMETRIC |
STORANDT, MARTHA |
5P01AG003991-25 |
2008 |
$174932 |
9 |
NOVEL BIOMARKERS TO PREDICT ALZHEIMER DISEASE |
HOLTZMAN, DAVID M |
5P01AG003991-25 |
2008 |
$150947 |
13 |
PREDICTING COGNITIVE DECLINE IN NONDEMENTED ELDER SUBJECTS |
CSERNANSKY, JOHN G |
5P01AG003991-25 |
2008 |
$173092 |
7 |
ATTENTION PROFILES IN HEALTHY AGING AND EARLY STAGE DAT |
BALOTA, DAVID A |
5P01AG003991-25 |
2008 |
$507516 |
9001 |
CORE--CLINICAL |
MORRIS, JOHN |